The authors of the research linking the malaria drug hydroxychloroquine and increased death risk during Covid-19 treatment have retracted the Lancet study as they were unable to share the full dataset for an independent peer-review."Several concerns were raised with respect to the veracity of the data and analyses conducted by Surgisphere Corporation and its founder and our co-author, Sapan Desai, in our publication," the authors of the study wrote.
Read full Post
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment